Brief: Oragenics Announces Termination Of At-The-Market Offering Program
23/01/2024 22:46
Oragenics Inc OGEN.A :
* ORAGENICS ANNOUNCES TERMINATION OF AT-THE-MARKET OFFERING
PROGRAM
* ORAGENICS INC - INITIATED 5-DAY TERMINATION PROCESS OF ATM
OFFERING, WITH TERMINATION TO TAKE EFFECT ON JANUARY 30, 2024
Source text for Eikon: ID:nBw9VCGp0a
Further company coverage: OGEN.A
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing